/Companies

페프로민바이오

Irvine, US · 1 known investors

Find your way into 페프로민바이오

Sign up to see every warm intro you have to 페프로민바이오

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 페프로민바이오 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.

Founders & leadership

NHNicolas Hwang
Nicolas HwangChief Executive Officer
APAndrew Park
Andrew ParkChief Financial Officer

Investors · 1

Related companies · 3

Companies working in the same space as 페프로민바이오.

Frequently asked questions

What does 페프로민바이오 do?
PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.
Who are 페프로민바이오's investors?
페프로민바이오's investors include Solidus Investment.
Where is 페프로민바이오 headquartered?
페프로민바이오 is headquartered in Irvine, US.